Savara Inc - Common Stock, par value $0.001 per share (SVRA)

CUSIP: 805111101

Q4 2024 13F Holders as of 31 Dec 2024

Holder snapshot 7 signals
Share change
+2,852,184
Put/Call ratio
1.1%
SEC-reported price per share
$3.07
Number of holders
134
Value change
-$4,524,160
Number of buys
73
Show 1 more signal
Number of sells
49
Security identity 1 source field
Shares outstanding
210,922,101

Security key

805111101

Report period

Q4 2024

Institutions

134

Top holders

10

Ownership snapshot

Top reported holders of SVRA - Savara Inc - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
WELLINGTON MANAGEMENT GRO...
Disclosed value leader
NEA Management Company, LLC
Comparable rows
15/15
Latest evidence
30 Sep 2024
13F 13D/G Lead comparable stake: 3.2% 13D/G row: WELLINGTON MANAGEMENT GROUP LLP Showing 1-6 of 15 holder rows.

Quick read

WELLINGTON MANAGEMENT GROUP LLP leads the comparable SEC ownership view at 3.2%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Comparable ownership Top 5
WELLINGTON MANAGEMENT GROUP LLP 3.2%
NEA Management Company, LLC 12%
Bain Capital Life Sciences Invest... 6.9%
TCG Crossover Management, LLC 5.9%
BlackRock, Inc. 4.5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
WELLINGTON MANAGEMENT GROUP LLP
13F 13D/G
Company
3.2%
from 13D/G
$36,565,810
8,624,012 shares
30 Sep 2024
NEA Management Company, LLC
13F
Company
13F
12%
$103,758,159
24,471,264 shares
30 Sep 2024
Bain Capital Life Sciences Investors, LLC
13F
Company
13F
6.9%
$61,757,538
14,565,457 shares
30 Sep 2024
TCG Crossover Management, LLC
13F
Company
13F
5.9%
$52,415,749
12,362,205 shares
30 Sep 2024
BlackRock, Inc.
13F
Company
13F
4.5%
$39,852,130
9,399,087 shares
30 Sep 2024
Frazier Life Sciences Management, L.P.
13F
Company
13F
3.9%
$34,587,312
8,157,385 shares
30 Sep 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
134
Shares
162,865,251
Rows available
134
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
124
Q4 2024 holders
134
Holder diff
10
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 value Q4 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .